Analysis of Profitability Ratios
Quarterly Data
Beginner level
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Intuitive Surgical Inc., profitability ratios (quarterly data)
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Intuitive Surgical Inc.’s gross profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Intuitive Surgical Inc.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Intuitive Surgical Inc.’s net profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Intuitive Surgical Inc.’s ROE deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Intuitive Surgical Inc.’s ROA deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Gross Profit Margin
Intuitive Surgical Inc., gross profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Gross profit | 502,900 | 738,200 | 896,000 | 785,600 | 759,000 | 669,600 | 735,700 | 642,300 | 632,300 | 593,800 | 633,300 | 566,800 | 527,900 | 466,100 | 527,200 | 487,000 | 470,900 | 405,000 | 458,800 | 395,800 | 386,500 | 336,800 | |||||||
| Revenue | 852,100 | 1,099,500 | 1,277,700 | 1,128,200 | 1,098,900 | 973,700 | 1,046,500 | 920,900 | 909,300 | 847,500 | 892,400 | 806,100 | 756,200 | 674,200 | 756,900 | 682,900 | 670,100 | 594,500 | 676,500 | 589,700 | 586,100 | 532,100 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Gross profit margin1 | 67.07% | 69.04% | 69.45% | 69.45% | 69.47% | 69.60% | 69.92% | 70.07% | 70.22% | 70.31% | 70.12% | 69.75% | 69.97% | 70.08% | 69.89% | 69.42% | 68.38% | 67.28% | 66.18% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Gross Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 46.24% | 47.78% | 47.94% | 47.42% | 47.28% | 45.04% | 45.44% | 45.60% | 46.00% | 49.30% | 49.14% | 48.86% | 48.57% | 48.59% | 47.99% | 47.66% | 44.92% | 45.09% | 45.66% | 46.34% | 50.87% | 50.83% | |||||||
| Boston Scientific Corp. | 68.26% | 70.41% | 70.98% | 71.20% | 71.33% | 71.12% | 71.37% | 71.48% | 71.35% | 71.78% | 71.34% | 71.27% | 71.38% | 70.86% | 71.09% | 70.88% | 70.78% | 70.99% | 70.94% | — | — | — | |||||||
| Danaher Corp. | 55.28% | 55.85% | 55.74% | 55.61% | 55.53% | 55.71% | 55.83% | 56.03% | 56.18% | 55.80% | 55.61% | 55.27% | 55.09% | 55.36% | 55.29% | 54.16% | 53.47% | 52.86% | 52.34% | — | — | — | |||||||
| Medtronic PLC | 69.22% | 69.62% | 70.04% | 70.33% | 70.40% | 70.25% | 69.77% | 69.40% | 69.05% | 68.67% | 68.73% | 68.60% | 68.66% | 68.85% | 68.29% | 66.00% | 66.48% | 67.07% | 68.86% | — | — | — | |||||||
| Stryker Corp. | 63.34% | 65.15% | 65.14% | 64.95% | 65.29% | 65.47% | 65.72% | 65.69% | 65.55% | 65.58% | 65.68% | 66.12% | 66.16% | 65.87% | 66.18% | 66.42% | 66.67% | 67.01% | 66.38% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 45.39% | 44.30% | 44.35% | 44.48% | 44.51% | 44.60% | 44.57% | 44.36% | 44.55% | 44.68% | 45.15% | 45.67% | 45.88% | 45.90% | 45.80% | 45.62% | 45.60% | 45.51% | 45.72% | — | — | — | |||||||
| UnitedHealth Group Inc. | 25.95% | 23.52% | 23.19% | 22.92% | 22.89% | 23.15% | 23.33% | 23.36% | 23.33% | 23.28% | 22.98% | 23.09% | 23.12% | 22.99% | 23.13% | 22.35% | 22.20% | 22.73% | 23.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
1 Q2 2020 Calculation
Gross profit margin = 100
× (Gross profitQ2 2020
+ Gross profitQ1 2020
+ Gross profitQ4 2019
+ Gross profitQ3 2019)
÷ (RevenueQ2 2020
+ RevenueQ1 2020
+ RevenueQ4 2019
+ RevenueQ3 2019)
= 100 × (502,900 + 738,200 + 896,000 + 785,600)
÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200)
= 67.07%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Intuitive Surgical Inc.’s gross profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Operating Profit Margin
Intuitive Surgical Inc., operating profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Income from operations | 80,600 | 283,000 | 397,600 | 365,700 | 359,000 | 252,200 | 332,000 | 313,300 | 277,400 | 276,700 | 327,000 | 278,600 | 257,500 | 191,500 | 264,400 | 256,400 | 245,400 | 179,000 | 245,900 | 189,900 | 173,800 | 130,400 | |||||||
| Revenue | 852,100 | 1,099,500 | 1,277,700 | 1,128,200 | 1,098,900 | 973,700 | 1,046,500 | 920,900 | 909,300 | 847,500 | 892,400 | 806,100 | 756,200 | 674,200 | 756,900 | 682,900 | 670,100 | 594,500 | 676,500 | 589,700 | 586,100 | 532,100 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Operating profit margin1 | 25.86% | 30.52% | 30.69% | 30.82% | 31.10% | 30.51% | 32.21% | 33.46% | 33.56% | 34.52% | 33.71% | 33.14% | 33.79% | 34.40% | 34.95% | 35.32% | 33.99% | 32.23% | 31.04% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 9.23% | 7.91% | 10.18% | 12.98% | 12.37% | 12.63% | 9.37% | 9.29% | 4.69% | 7.32% | 12.22% | 9.29% | 15.17% | 15.21% | 11.46% | 13.23% | 10.22% | 9.60% | 10.45% | 12.53% | 17.60% | 18.59% | |||||||
| Boston Scientific Corp. | 6.58% | 10.41% | 14.14% | 15.66% | 16.19% | 16.50% | 15.33% | 15.57% | 15.74% | 14.33% | 14.20% | 12.53% | 12.36% | 6.04% | 5.33% | 0.44% | -7.68% | -0.76% | -4.37% | — | — | — | |||||||
| Danaher Corp. | 17.37% | 18.01% | 18.25% | 17.46% | 17.61% | 17.41% | 17.11% | 17.27% | 17.23% | 16.69% | 16.48% | 15.73% | 15.69% | 16.09% | 16.29% | 16.51% | 16.27% | 16.81% | 16.87% | — | — | — | |||||||
| Medtronic PLC | 20.47% | 21.25% | 20.51% | 20.48% | 20.22% | 21.70% | 22.20% | 21.35% | 20.47% | 18.55% | 17.94% | 17.72% | 18.65% | 18.54% | 18.35% | 14.56% | 15.72% | 16.37% | 18.59% | — | — | — | |||||||
| Stryker Corp. | 15.54% | 18.86% | 18.23% | 16.96% | 17.00% | 17.83% | 18.65% | 19.22% | 19.16% | 18.28% | 18.40% | 18.46% | 18.42% | 18.68% | 19.13% | 19.78% | 19.53% | 19.62% | 18.71% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 17.05% | 17.86% | 17.99% | 17.88% | 18.00% | 15.90% | 15.53% | 15.03% | 14.36% | 14.23% | 14.19% | 13.94% | 13.89% | 13.62% | 13.40% | 13.28% | 13.68% | 13.65% | 13.77% | — | — | — | |||||||
| UnitedHealth Group Inc. | 9.89% | 8.12% | 8.19% | 8.02% | 7.97% | 7.88% | 7.71% | 7.70% | 7.68% | 7.67% | 7.60% | 7.37% | 7.26% | 7.11% | 7.03% | 6.78% | 6.64% | 6.87% | 7.05% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
1 Q2 2020 Calculation
Operating profit margin = 100
× (Income from operationsQ2 2020
+ Income from operationsQ1 2020
+ Income from operationsQ4 2019
+ Income from operationsQ3 2019)
÷ (RevenueQ2 2020
+ RevenueQ1 2020
+ RevenueQ4 2019
+ RevenueQ3 2019)
= 100 × (80,600 + 283,000 + 397,600 + 365,700)
÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200)
= 25.86%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Intuitive Surgical Inc.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Net Profit Margin
Intuitive Surgical Inc., net profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 68,000 | 313,500 | 357,700 | 396,800 | 318,300 | 306,500 | 292,500 | 292,500 | 255,300 | 287,600 | (38,800) | 297,500 | 221,500 | 179,800 | 204,000 | 211,000 | 184,500 | 136,400 | 190,000 | 167,300 | 134,500 | 97,000 | |||||||
| Revenue | 852,100 | 1,099,500 | 1,277,700 | 1,128,200 | 1,098,900 | 973,700 | 1,046,500 | 920,900 | 909,300 | 847,500 | 892,400 | 806,100 | 756,200 | 674,200 | 756,900 | 682,900 | 670,100 | 594,500 | 676,500 | 589,700 | 586,100 | 532,100 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Net profit margin1 | 26.07% | 30.11% | 30.80% | 30.94% | 29.95% | 29.78% | 30.29% | 22.31% | 23.20% | 23.25% | 21.09% | 30.16% | 28.44% | 27.99% | 27.21% | 27.51% | 26.80% | 25.67% | 24.69% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 6.17% | 5.25% | 7.13% | 5.47% | 6.33% | 6.13% | 1.95% | 5.23% | 0.34% | 3.28% | 9.10% | 6.52% | 10.67% | 10.54% | 7.82% | 9.24% | 6.62% | 6.13% | 6.76% | 8.65% | 12.75% | 13.56% | |||||||
| Boston Scientific Corp. | 39.24% | 39.75% | 43.78% | 10.49% | 13.85% | 18.08% | 17.01% | 6.93% | 5.48% | 1.21% | 1.15% | 9.55% | 9.04% | 5.07% | 4.14% | 0.99% | -4.34% | -0.47% | -3.20% | — | — | — | |||||||
| Danaher Corp. | 18.35% | 18.13% | 16.80% | 13.01% | 13.11% | 12.45% | 13.33% | 14.07% | 13.84% | 13.56% | 13.60% | 13.36% | 12.63% | 13.41% | 15.13% | 13.72% | 18.39% | 17.92% | 16.33% | — | — | — | |||||||
| Medtronic PLC | 15.11% | 14.41% | 15.16% | 16.10% | 7.44% | 10.56% | 10.36% | 9.44% | 16.93% | 13.75% | 13.56% | 13.51% | 14.62% | 12.70% | 12.27% | 8.52% | 8.92% | 11.28% | 13.20% | — | — | — | |||||||
| Stryker Corp. | 11.38% | 14.47% | 13.99% | 23.55% | 24.99% | 25.38% | 26.12% | 9.31% | 8.28% | 8.00% | 8.20% | 14.67% | 14.22% | 14.33% | 14.54% | 15.24% | 15.33% | 16.07% | 14.47% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 14.12% | 14.31% | 14.47% | 14.24% | 14.24% | 12.89% | 12.06% | 10.75% | 10.36% | 10.24% | 10.64% | 11.74% | 11.80% | 11.58% | 11.06% | 11.10% | 11.35% | 11.49% | 11.64% | — | — | — | |||||||
| UnitedHealth Group Inc. | 6.94% | 5.63% | 5.76% | 5.61% | 5.55% | 5.49% | 5.33% | 5.75% | 5.58% | 5.43% | 5.28% | 4.41% | 4.23% | 4.03% | 3.81% | 3.64% | 3.52% | 3.64% | 3.72% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
1 Q2 2020 Calculation
Net profit margin = 100
× (Net income attributable to Intuitive Surgical, Inc.Q2 2020
+ Net income attributable to Intuitive Surgical, Inc.Q1 2020
+ Net income attributable to Intuitive Surgical, Inc.Q4 2019
+ Net income attributable to Intuitive Surgical, Inc.Q3 2019)
÷ (RevenueQ2 2020
+ RevenueQ1 2020
+ RevenueQ4 2019
+ RevenueQ3 2019)
= 100 × (68,000 + 313,500 + 357,700 + 396,800)
÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200)
= 26.07%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Intuitive Surgical Inc.’s net profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Return on Equity (ROE)
Intuitive Surgical Inc., ROE calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 68,000 | 313,500 | 357,700 | 396,800 | 318,300 | 306,500 | 292,500 | 292,500 | 255,300 | 287,600 | (38,800) | 297,500 | 221,500 | 179,800 | 204,000 | 211,000 | 184,500 | 136,400 | 190,000 | 167,300 | 134,500 | 97,000 | |||||||
| Total Intuitive Surgical, Inc. stockholders’ equity | 8,740,500 | 8,506,700 | 8,263,800 | 7,761,400 | 7,265,300 | 7,024,200 | 6,678,800 | 6,280,600 | 5,860,600 | 5,497,100 | 4,725,200 | 4,957,900 | 4,522,300 | 4,127,500 | 5,777,800 | 5,541,800 | 5,181,500 | 4,750,400 | 4,319,500 | 4,115,200 | 3,792,700 | 3,585,400 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROE1 | 13.00% | 16.30% | 16.69% | 16.93% | 16.65% | 16.33% | 16.89% | 12.68% | 13.68% | 13.97% | 13.97% | 18.21% | 18.05% | 18.88% | 12.74% | 13.03% | 13.09% | 13.22% | 13.63% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROE, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 5.13% | 4.30% | 5.85% | 4.35% | 5.06% | 4.89% | 1.48% | 3.61% | 0.22% | 1.89% | 8.50% | 6.30% | 16.51% | 17.26% | 12.79% | 14.17% | 10.57% | 9.53% | 9.70% | 11.24% | 15.07% | 22.69% | |||||||
| Boston Scientific Corp. | 25.53% | 31.06% | 33.87% | 11.24% | 14.81% | 19.46% | 19.15% | 8.08% | 6.73% | 1.59% | 1.48% | 11.11% | 10.89% | 6.17% | 5.15% | 1.25% | -5.55% | -0.56% | -3.78% | — | — | — | |||||||
| Danaher Corp. | 9.56% | 10.53% | 9.94% | 7.63% | 7.69% | 7.66% | 9.40% | 9.98% | 9.81% | 9.39% | 9.45% | 9.39% | 8.95% | 9.68% | 11.10% | 10.76% | 14.00% | 14.47% | 14.17% | — | — | — | |||||||
| Medtronic PLC | 9.23% | 8.78% | 9.25% | 9.87% | 4.56% | 6.30% | 6.12% | 5.59% | 9.75% | 8.12% | 8.01% | 8.03% | 8.45% | 7.18% | 6.80% | 4.79% | 4.43% | 4.97% | 5.03% | — | — | — | |||||||
| Stryker Corp. | 12.55% | 16.50% | 16.26% | 27.82% | 29.72% | 30.12% | 30.29% | 12.54% | 11.42% | 11.06% | 10.23% | 17.06% | 16.94% | 17.41% | 17.25% | 17.78% | 17.64% | 18.36% | 16.91% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 12.41% | 12.85% | 12.45% | 12.24% | 12.33% | 11.46% | 10.65% | 9.55% | 9.05% | 8.62% | 8.76% | 9.42% | 10.12% | 9.96% | 9.39% | 9.21% | 9.39% | 9.52% | 9.25% | — | — | — | |||||||
| UnitedHealth Group Inc. | 26.87% | 24.14% | 24.02% | 24.25% | 24.46% | 24.39% | 23.19% | 25.12% | 24.56% | 23.60% | 22.10% | 19.04% | 18.79% | 18.08% | 18.33% | 17.40% | 16.98% | 17.09% | 17.18% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
1 Q2 2020 Calculation
ROE = 100
× (Net income attributable to Intuitive Surgical, Inc.Q2 2020
+ Net income attributable to Intuitive Surgical, Inc.Q1 2020
+ Net income attributable to Intuitive Surgical, Inc.Q4 2019
+ Net income attributable to Intuitive Surgical, Inc.Q3 2019)
÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 100 × (68,000 + 313,500 + 357,700 + 396,800)
÷ 8,740,500 = 13.00%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Intuitive Surgical Inc.’s ROE deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Return on Assets (ROA)
Intuitive Surgical Inc., ROA calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 68,000 | 313,500 | 357,700 | 396,800 | 318,300 | 306,500 | 292,500 | 292,500 | 255,300 | 287,600 | (38,800) | 297,500 | 221,500 | 179,800 | 204,000 | 211,000 | 184,500 | 136,400 | 190,000 | 167,300 | 134,500 | 97,000 | |||||||
| Total assets | 10,103,600 | 9,891,100 | 9,733,200 | 9,131,300 | 8,531,600 | 8,234,900 | 7,846,700 | 7,318,600 | 6,849,600 | 6,426,200 | 5,758,000 | 5,644,600 | 5,250,800 | 4,808,000 | 6,486,900 | 6,174,700 | 5,780,800 | 5,306,300 | 4,907,300 | 4,682,300 | 4,354,500 | 4,126,200 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROA1 | 11.24% | 14.02% | 14.17% | 14.39% | 14.18% | 13.93% | 14.37% | 10.88% | 11.70% | 11.95% | 11.46% | 15.99% | 15.55% | 16.21% | 11.34% | 11.69% | 11.73% | 11.84% | 12.00% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROA, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 2.01% | 1.76% | 2.38% | 1.79% | 2.05% | 1.98% | 0.58% | 1.43% | 0.08% | 0.73% | 2.92% | 2.13% | 5.45% | 5.38% | 3.81% | 4.37% | 3.09% | 2.64% | 2.59% | 3.01% | 3.81% | 6.22% | |||||||
| Boston Scientific Corp. | 12.93% | 14.24% | 15.38% | 4.07% | 5.74% | 7.55% | 7.96% | 3.29% | 2.66% | 0.58% | 0.55% | 4.52% | 4.29% | 2.42% | 1.92% | 0.46% | -1.93% | -0.20% | -1.32% | — | — | — | |||||||
| Danaher Corp. | 4.86% | 4.74% | 4.85% | 4.03% | 4.64% | 4.67% | 5.54% | 5.79% | 5.55% | 5.41% | 5.34% | 5.20% | 4.82% | 5.09% | 5.64% | 6.04% | 6.81% | 7.33% | 6.96% | — | — | — | |||||||
| Medtronic PLC | 5.13% | 4.84% | 5.16% | 5.54% | 2.56% | 3.53% | 3.40% | 2.93% | 5.31% | 4.10% | 4.04% | 4.07% | 4.31% | 3.70% | 3.55% | 2.37% | 2.21% | 2.51% | 2.51% | — | — | — | |||||||
| Stryker Corp. | 5.09% | 7.35% | 6.90% | 12.85% | 13.47% | 13.58% | 13.05% | 5.60% | 5.01% | 4.60% | 4.60% | 8.28% | 7.98% | 8.23% | 8.06% | 8.22% | 7.82% | 8.22% | 8.86% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 6.02% | 6.25% | 6.33% | 6.33% | 6.11% | 5.71% | 5.22% | 4.66% | 4.32% | 3.98% | 3.93% | 4.16% | 4.87% | 4.70% | 4.40% | 4.16% | 4.73% | 4.64% | 4.83% | — | — | — | |||||||
| UnitedHealth Group Inc. | 8.88% | 7.27% | 7.96% | 7.68% | 7.77% | 7.83% | 7.87% | 8.32% | 7.67% | 7.21% | 7.59% | 6.14% | 5.87% | 5.53% | 5.71% | 5.30% | 5.17% | 5.10% | 5.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).
1 Q2 2020 Calculation
ROA = 100
× (Net income attributable to Intuitive Surgical, Inc.Q2 2020
+ Net income attributable to Intuitive Surgical, Inc.Q1 2020
+ Net income attributable to Intuitive Surgical, Inc.Q4 2019
+ Net income attributable to Intuitive Surgical, Inc.Q3 2019)
÷ Total assets
= 100 × (68,000 + 313,500 + 357,700 + 396,800)
÷ 10,103,600 = 11.24%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Intuitive Surgical Inc.’s ROA deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |